Deborah Ann Bryan

age ~64

from Wilmington, DE

Get Report

Also known as:

Deborah A Bryan
Deborah A Sexton
Bryan Deborah Ann
Deborah Ann N

Phone and address:: 102 Brier Ave, Wilmington, DE 19805
3027785105

Connected to:

Deborah Bryan Phones & Addresses

102 Brier Ave, Wilmington, DE 19805 • 3027785105
2003 Waters Edge Dr, Newark, DE 19702
Bear, DE
North East, MD

Work

Position:

Clerical/White Collar

Education

Degree:

High school graduate or higher

Specialities

Family Law • Government Contracts Law

Resumes

Owner At Bryan And Associates, Realtors

view source

Location:

United States

Industry:

Real Estate

Deborah Bryan

view source

Deborah Bryan

view source

Deborah Bryan

view source

Deborah Bryan

view source

Deborah Bryan

view source

Owner, Dbcglass

view source

Position:

Owner at DBCGlass

Location:

Greater Philadelphia Area

Industry:

Glass, Ceramics & Concrete

Work:

DBCGlass
Owner

Us Patents

Il-8 Receptor Antagonists
view source
US Patent:

6335352, Jan 1, 2002
Filed:

Feb 4, 1999
Appl. No.:

09/230981
Inventors:

Deborah Lynn Bryan - West Chester PA
John Gerald Gleason - Downington PA
Katherine L. Widdowson - King of Prussia PA
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 31435
US Classification:

514345, 514352, 514357, 546304, 546330, 546329, 546290, 546291
Abstract:

Novel compounds useful in the treatment of Interleukin-8 mediated diseases, and methods of using them are disclosed.

Quinoline Inhibitors Of Hyaki And Hyak3 Kinases
view source
US Patent:

7087758, Aug 8, 2006
Filed:

Apr 4, 2002
Appl. No.:

10/474084
Inventors:

Deborah L. Bryan - King of Prussia PA, US
Joelle L. Burgess - Collegeville PA, US
James F. Callahan - Collegeville PA, US
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 31/47
C07D 215/38
C07D 215/12
US Classification:

546161, 546167, 546159, 514311, 514314
Abstract:

This invention relates to novel quinoline inhibitors of hYAK1 and hYAK3 kinases and pharmaceutically acceptable salts, hydrates or solvates thereof, pharmaceutical compositions thereof, and methods of treatment of diseases in which an excessive amount of either such kinase is a factor.

4-Amino-2,3-Disubstituted Thieno[2,3-D]Pyrimidines And Pharmacetical Compositions Thereof
view source
US Patent:

7427623, Sep 23, 2008
Filed:

Sep 10, 2002
Appl. No.:

10/489052
Inventors:

Jerry Leroy Adams - King of Prussia PA, US
Deborah Lynne Bryan - King of Prussia PA, US
Yanhong Feng - Collegeville PA, US
Shinichiro Matsunaga - Tsukuba, JP
Yutaka Maeda - Tsukuba, JP
Yasushi Miyazaki - Tsukuba, JP
Masato Nakano - Tsukuba, JP
Jean-Philippe Rocher - Vetraz-Mothoux, FR
Hideyuki Sato - Tsukuba, JP
Marcus Semones - Collegeville PA, US
Domingos J. Silva - Collegeville PA, US
Jun Tang - Tsukuba, JP
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 31/519
C07D 495/04
A61P 35/00
A61P 9/00
US Classification:

5142601, 544278
Abstract:

Furo- and thienopyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such furo- and thienopyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Compounds
view source
US Patent:

7449484, Nov 11, 2008
Filed:

Mar 23, 2006
Appl. No.:

11/388058
Inventors:

Jerry L. Adams - King of Prussia PA, US
Deborah L. Bryan - King of Prussia PA, US
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 31/4439
C07D 401/04
US Classification:

514341, 5462741
Abstract:

The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.

Anthranilamide Inhibitors Of Aurora Kinase
view source
US Patent:

7625903, Dec 1, 2009
Filed:

Jan 25, 2008
Appl. No.:

12/019730
Inventors:

Neil W. Johnson - Collegeville PA, US
Deborah L. Bryan - Collegeville PA, US
Assignee:

SmithKline Beecham Corporation - Philadelphia PA
International Classification:

A61K 31/497
C07D 403/00
US Classification:

51425214, 544295
Abstract:

The present invention relates to a compound represented by the following formula:.

Anthranilamide Inhibitors Of Aurora Kinase
view source
US Patent:

7884098, Feb 8, 2011
Filed:

Jan 25, 2008
Appl. No.:

12/524009
Inventors:

Jeffrey Michael Axten - Collegeville PA, US
Deborah L. Bryan - Collegeville PA, US
David Harold Drewry - Durham NC, US
Thomas H Faitg - Collegeville PA, US
Timothy Francis Gallagher - Collegeville PA, US
Neil W Johnson - Collegeville PA, US
Jiri Kasparec - Collegeville PA, US
Jeffrey M Ralph - Collegeville PA, US
Domingos J. Silva - Collegeville PA, US
Assignee:

GlaxoSmithKline LLC - Philadelphia PA
International Classification:

A61K 31/5355
A61K 31/541
A61K 31/505
A61K 31/506
C07D 279/12
C07D 403/02
C07D 239/24
C07D 413/02
US Classification:

5142278, 5142358, 51425214, 514275, 544 582, 544 584, 544122, 544295, 544323
Abstract:

The present invention relates to a compound represented by the following formula:.

Novel Compounds
view source
US Patent:

20040053943, Mar 18, 2004
Filed:

May 20, 2003
Appl. No.:

10/432092
Inventors:

Jerry Adams - King of Prussia PA, US
Deborah Bryan - King of Prussia PA, US
International Classification:

A61K031/505
C 07D 4 3/04
C 07D 4 3/14
A61K031/4745
A61K031/4439
US Classification:

514/256000, 514/341000, 544/333000, 546/272700, 544/294000
Abstract:

The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.

Chemical Compounds
view source
US Patent:

20060241149, Oct 26, 2006
Filed:

Nov 6, 2003
Appl. No.:

10/533832
Inventors:

Jerry Adams - Collegeville PA, US
Deborah Bryan - King of Prussia PA, US
Jiri Kasparec - King of Prussia PA, US
Francis King - King of Prussia PA, US
Andrew Takle - King of Prussia PA, US
David Wilson - King of Prussia PA, US
Steven Goodman - King of Prussia PA, US
International Classification:

A61K 31/4439
C07D 403/02
US Classification:

514337000, 546277400
Abstract:

Pyridinyl-benzoheterocycyl kinase inhibitor compounds are disclosed. Also disclosed are methods of making such compounds as well as methods of using the same in the treatment of diseases.